Clinical Trial Update: Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing four vs six cycles of cisplatin-based chemotherapy in metastatic urothelial carcinoma is ongoing/unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Transitional Cell Carcinoma
• Ureter Cancer
• Urethral Cancer

Drugs mentioned

• cisplatin-based chemotherapy (cisplatin)

Snippet

Sponsor: Asan Medical Center | Conditions: Bladder Cancer, Ureter Cancer | Phase 3 | Status: UNKNOWN